Journal Articles (past 5 years)
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30068-4
Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, Sy S, Regan C, Keane A, Caruana M, Nguyen DTN, Smith MA, Laprise JF, Jit M, Alary M, Bray F, Fidarova E, Elsheikh F, Bloem PJN, Broutet N, Hutubessy R.
Mortality reductions and lives saved on the path to eliminating cervical cancer in 78 Low and Lower-Middle Income Countries: Comparative modelling of impact of achieving WHO targets for scaling up vaccination, cervical screening and cancer treatment services
The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30157-4
Canfell K, Kim J, Brisson M, Keane A, Simms K, Caruana M, Burger E, Martin D, Nguyen DTN, Benard É, Sy S, Regan C, Laprise JF, Torode J, Smith M, Fidarova E, Trapani D, Ilbawi A, Broutet N, Hutubessy R
HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
Papillomavirus research, ISSN: 2405-8521, Vol: 8 (2019), Page: 100184
Canfell K, Kim JJ, Kulasingam S, Berkhof J, Barnabas R, Bogaards JA, Campos N, Jennett C, Sharma M, Simms KT, Smith MA, Velentzis LS, Brisson M, Jit M
Guidelines for multi-model comparisons of the impact of infectious disease interventions
BMC Med. 2019 Aug 19;17(1):163. doi: 10.1186/s12916-019-1403-9
den Boon S, Jit M, Brisson M, Medley G, Beutels P, White R, Flasche S, Hollingsworth TD, Garske T, Pitzer VE, Hoogendoorn M, Geffen O, Clark A, Kim J, Hutubessy R
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool
Vaccine. 2019 Jul 18;37(31):4376-4381. doi: 10.1016/j.vaccine.2019.06.019. Epub 2019 Jun 24
Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr, Brisson M, Mahon BE, Henao-Restrepo AM
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study
Hum Vaccin Immunother. 2019 Jul 16:1-9. doi: 10.1080/21645515.2019.1619402
Bolotin S, Severini A, Hatchette T, McLachlan E, Savage R, Hughes SL, Wang J, Deeks SL, Wilson S, Brisson M, Halperin SA, Gubbay J, Mazzulli T, Serhir B, Ward BJ, Crowcroft N
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models
Lancet Pub Health 2016;1(1):e8-17
Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.
Emerg Infect Dis. 2016;22(10):1732-40. doi: 10.3201/eid2210.160675.
Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, Söderlund-Strand A, Sonnenberg P, Tabrizi SN, Tanton C, Unger E, Thomas SL
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
The Lancet ID. 2015;15(5):565-80
Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer h, Beddows S, Brisson J, Brotherton JML, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M